Authors: Fish, JE Karpel, JP Craig, TJ Bensch, GW Noonan, M Webb, DR Silverman, B Schenkel, EJ Rooklin, AR Ramsdell, JW Nathan, R Leflein, JG Grossman, J Graft, DF Gower, RG Garay, SM Frigas, E DeGraff, AC Bronsky, EA Bernstein, DI Berger, W Shneyer, L Nolop, KB Harrison, JE

Citation: Je. Fish et al., Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related duality of life in patients with severe persistent asthma, J ALLERG CL, 106(5), 2000, pp. 852-860

Authors: Schenkel, EJ Skoner, DP Bronsky, EA Miller, SD Pearlman, DS Rooklin, A Rosen, JP Ruff, ME Vandewalker, ML Wanderer, A Damaraju, CV Nolop, KB Mesarina-Wicki, B

Citation: Ej. Schenkel et al., Absence of growth retardation in children with perennial allergic rhinitisafter one year of treatment with mometasone furoate aqueous nasal spray, PEDIATRICS, 105(2), 2000, pp. E221-E227

Authors: Edelman, JM Turpin, JA Bronsky, EA Grossman, J Kemp, JP Ghannam, AF DeLucca, PT Gormley, GJ Pearlman, DS

Citation: Jm. Edelman et al., Oral Montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction - A randomized, double-blind trial, ANN INT MED, 132(2), 2000, pp. 97-104

Authors: Meltzer, EO Berger, WE Berkowitz, RB Bronsky, EA Dvorin, DJ Finn, AF Galant, SP Grossman, J Hampel, FC Ratner, PH Ruff, ME Schenkel, EJ Segal, AT Segall, N Stewart, GE Tripathy, I Skoner, DP Anolik, R Dockhorn, RJ van Bavel, J Mesarina-Wicki, B Nolop, KB

Citation: Eo. Meltzer et al., A dose-ranging study of mometasone furoate aqueous nasal spray in childrenwith seasonal allergic rhinitis, J ALLERG CL, 104(1), 1999, pp. 107-114

Authors: Bronsky, EA Pearlman, DS Pobiner, BF Scott, C Wang, YH Stahl, E

Citation: Ea. Bronsky et al., Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices, PEDIATRICS, 104(3), 1999, pp. 501-506

Authors: Pearlman, DS Ostrom, NK Bronsky, EA Bonuccelli, CM Hanby, LA

Citation: Ds. Pearlman et al., The leukotriene D-4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children, J PEDIAT, 134(3), 1999, pp. 273-279